FN1 and fibrosis: BM-MSCs preconditioned with oncostatin M improved lung function and reduced lung edema, inflammatory cell counts, and fibrosis in bleomycin-induced lung fibrosis and reduced mRNA expression of fibronectin and type I collagen in co-cultured fibroblasts (Lan et al., 2017).